HIF1A and neoplasm: Succinate has been identified as having many pro-oncogenic roles, including HIF1α stabilisation [27, 28], alteration of the tumour microenvironment [32], promotion of metastatic potential via enhanced EMT [29], suppression of anti-tumour immune responses [33, 34] and the activation of pro-inflammatory signalling pathways [35].